Skip to main content

Table 2 HBVa, HCVb and HTLVc 1&2 seroprevalence by demographic and behavioral characteristics among MSMd and associated factors in Ouagadougou

From: Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso

Variables

n

HBV

HCV

HTLV 1&2

HBV positive

RDSe-adjusted

HBV Positive (95% CIf)

HCV positive

RDS-adjusted HCV Positive

(95% CI)

HTLV1&2 positive

RDS-adjusted HTLV1&2 Positive

(95% CI)

Current age (years)

 18–19

78

17.9

17.7 (10.7–27.8)

7.7

7.3 (3.2–15.5)

3.8

3.9 (1.3–11.5)

 20–24

196

19.9

19.6 (14.6–25.7)

13.3

13.3 (9.2–18.9)

4.1

4.1 (2.1–8.0)

 25–29

35

22.9

23.1 (12.0–40.0)

2.9

02.9 (0.4–18.0)

0.0

–

  > =30

20

35.0

35.9 (18.0–58.9)

15.6

16.4 (5.4–40.3)

10.0

10.9 (2.7–34.8)

Total

329

20.7

20.4 (16.4–25.1)

10.9

11.0 (8.0–14.8)

4.0

4.0 (2.3–6.8)

Country of birth

 Burkina Faso

272

21.0

20.7 (16.3–25.9)

9.9

09.9 (6.9–14.1)

4.0

4.1 (2.3–7.3)

 Other countries

57

19.3

18.8 (10.7–31.1)

15.8

16.0 (8.5–28.1)

3.5

3.6 (0.9–13.2)

Childhood environment

 Urban

288

20.3

20.0 (15.8–25.0)

10.8

10.8 (7.6–14.9)

4.2

4.2 (2.4–7.3)

 Rural

27

33.3

32.3 (17.5–51.7)

14.8

15.1 (5.7–34.0)

3.7

3.8 (0.5–22.6)

Highest educational level

 None or primary

25

24.0

24.4 (11.4–44.9)

4.0

4.1 (0.6–24.1)

4.0

4.1 (0.6–24.1)

 Secondary

239

16.5

16.2 (12.0–21.4)

11.7

11.7 (8.1–16.4)

4.2

4.2 (2.3–7.7)

 University

65

34.8

34.5 (23.9–46.7)

10.8

11.0 (5.3–21.4)

3.1

3.1 (0.8–11.8)

Occupation

 Student/pupil

236

18.1

17.9 (13.5–23.3)

12.3

12.2 (8.6–17.1)

3.8

3.8 (2.0–7.3)

 Employed

72

28.8

28.4 (19.2–39.9)

5.6

5.7 (2.2–14.3)

2.8

2.9 (0.7–10.8)

 Unemployed

21

22.7

21.2 (8.9–42.6)

14.3

14.3 (4.7–36.3)

9.5

9.5 (2.4–31.3)

Marital status (with a woman)

 Single

310

19.4

19.1 (15.1–23.9)

11.0

10.9 (7.9–15.0)

3.9

3.9 (2.2–6.8)

 Otherg

18

42.1

42.7 (22.8–65.3)

10.5

11.3 (2.8–35.7)

5.3

5.6 (0.8–31.2

Number of biological children

 0

305

20.8

20.5 (16.3–25.3)

10.5

10.5 (7.5–14.4)

3.9

4.0 (2.3–6.9)

  > =1

24

20.8

20.1 (8.4–40.8)

16.7

17.6 (6.8–38.6)

4.2

4.4 (0.6–25.6)

Sexual orientation

 Gay/homosexual

236

20.3

20.1 (15.5–25.7)

10.2

10.3 (7.0–14.9)

3.0

3.0 (1.4–6.2)

 Bisexual

21

31.8

30.5 (15.0–52.1)

19.0

19.0 (7.3–41.3)

4.8

4.8 (0.7–27.4)

 Heterosexual

72

19.2

18.4 (11.1–29.0)

11.1

10.8 (5.4–20.3)

6.9

7.1 (3.0–16.0)

Anal sex position

 Receptive

19

26.3

26.9 (11.6–50.7)

10.5

10.8 (2.7–34.5

0.0

0.0

 Insertive

310

20.5

20.1 (16.0–24.9)

11.0

11.0 (7.9–15.0)

5.0

5.0 (2.8–8.9)

Tested for STIh in the last 12 months

 No

241

18.7

18.5 (14.1–24.0)

12.0

12.0 (8.4–16.8)

3.8

3.4 (1.7–6.6)

 Yes

85

27.6

26.8 (18.5–37.1)

8.2

8.4 (4.0–16.6)

4.7

4.8 (1.8–12.2)

Past 12 month STI symptoms

 No

311

19.6

19.4 (15.4–24.3)

11.3

11.3 (8.2–15.3)

2.9

2.9 (1.5–5.6)

 Yes

18

38.9

37.4 (18.6–61.0)

5.6

5.7 (0.8–31.4)

22.2

22.8 (8.8–47.4)

Vaccinated against HBV

 No

264

22.7

22.4 (17.8–27.9)

10.2

10.2 (7.1–14.5)

3.0

3.1 (1.5–6.0)

 Yes

51

15.7

15.8 (8.1–28.6)

13.7

13.8 (6.7–26.4)

5.9

5.9 (1.9–16.9)

 Don’t know

14

0.0

–

14.3

14.3 (3.6–42.9)

14.3

14.3 (3.6–42.9)

At least 2 sexual partners in the last 12 months

 Only males

268

17.9

17.7 (13.6–22.8)

10.8

10.9 (7.7–15.3)

4.5

4.5 (2.6–7.8)

 Males and females

60

33.3

33.1 (22.3–46.0)

11.7

11.4 (5.4–22.2)

0.0

0

Type of sexual partners in the last 12 months

 Only males

201

19.9

19.8 (14.8–26.0)

12.9

12.9 (8.9–18.4)

2.0

2.0 (0.8–5.3)

 Males and females

127

22.0

21.5 (15.2–29.5)

7.9

7.9 (4.3–14.1)

6.3

6.3 (3.2–12.2)

Ever experienced condom tearing during anal sex

 No

218

17.4

17.4 (12.9–23.0)

11.9

12.0 (8.3–17.1)

4.6

4.6 (2.5–8.4)

 Yes

106

28.7

27.8 (20.1–37.0)

9.4

9.2 (5.0–16.4)

2.8

2.9 (0.9–8.6)

Condom use at last anal sex with a main male partner

 No

54

29.6

29.9 (19.1–43.4)

5.6

5.6 (1.8–16.1)

9.3

9.3 (3.9–20.6)

 Yes

240

17.1

16.6 (12.4–21.9)

11.3

11.2 (7.8–15.9)

2.1

2.1 (0.9–5.0)

Condom use at last anal sex with a casual male partner

 No

34

17.6

17.9 (8.2–34.6)

11.8

11.9 (4.5–27.9)

8.8

8.9 (2.9–24.4)

 Yes

224

19.6

19.2 (14.5–24.9)

10.3

10.4 (7.0–15.2)

3.6

3.6 (1.8–7.1)

HIVi status

 Positive

10

40.0

40.0 (15.7–70.4)

10.0

11.0 (8.0–14.9)

0

0.0

 Negative

319

20.1

20.1 (16.0–24.8)

11.0

10.0 (1.4–47.0)

4.1

4.1 (2.4–6.9)

Ever injected drugs

 No

323

20.7

20.5 (16.4–25.3)

11.0

11.2 (8.1–15.1)

3.7

3.8 (2.1–6.5)

 Yes

6

16.7

16.7 (2.3–63.4)

0.0

–

16.7

16.7 (2.3–63.4)

  1. aHBV Hepatitis B virus
  2. bHCV Hepatitis C virus
  3. cHTLV Human T-cell leukemia virus
  4. dMSM Men who have sex with men
  5. eRDS Respondent driven sampling
  6. fCI Confidence interval
  7. gMarried or cohabiting, divorced, separated
  8. hSTI Sexually transmitted infection
  9. iHIV Human immunodeficiency virus